A sign at the front entrance to the global headquarters of Illumina is pictured in San Diego, California
As an independent company, Grail is betting on commercial partnerships with health systems, employers and life insurance firms to power its near-term growth through its flagship cancer-detection test.The company's greater-than-expected expenditures and delays in advancing its tests had also forced Illumina to take impairments that totaled $4.7 billion, activist investor Carl Icahn said in December.
Departing Nvidia VP salutes Jensen Huang’s leadership, and pinpoints the 3 key principles he taught her
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more: